Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Matthew Paul Larson, Chief Risk Officer at Slide Insurance Holdings (NASDAQ: SLDE), sold 11,250 shares on March 30, 2026, for $202,500 and simultaneously exercised and sold 11,250 options at $0.79 each. The trades were executed under a pre-arranged 10b5-1 plan adopted December 4, 2025. Slide reported robust fourth-quarter 2025 earnings and announce…
Alset International Ltd sold 100,390 shares of HWH International Inc on March 30, 2026 at a weighted average price of $0.983, generating $98,683 in proceeds. The sale left Alset International Limited with an indirect holding of 1,891,279 HWH shares. Separately, HWH has agreed to buy 99.55% of Hapi Metaverse Inc for $19.9 million via a five-year pro…
Christopher Longhito, Senior Vice President and Chief Supply Chain Officer at Global Industrial Co (NASDAQ: GIC), sold a total of $385,013 in common stock across multiple transactions from March 23 to March 27, 2026. On March 27 he also exercised options that cost $131,775. Following the reported trades and exercises, Longhito is listed as owning z…
Trupanion Inc.’s Chief Operating Officer John R. Gallagher sold 430 shares on March 30, 2026, at $25.47 per share, yielding $10,952. The transaction, executed under a Rule 10b5-1 trading plan adopted on August 20, 2025, leaves Gallagher with 31,957 shares. The stock is trading near its 52-week low of $24.32 and is down 41% over the past six months.…
Karen Krasney, Executive Vice President and General Counsel of Capricor Therapeutics (NASDAQ: CAPR), sold 25,000 shares on March 31, 2026 for $752,935 and simultaneously exercised options to acquire 25,000 shares. The disposal was carried out under a pre-established 10b5-1 trading plan. Capricor recently reported a Q4 fiscal 2025 EPS miss and conti…
Capricor Therapeutics CFO Anthony Bergmann sold 25,000 shares on March 31, 2026, under a 10b5-1 plan for roughly $753,152 and exercised options to acquire 25,000 shares at $3.18 each. The moves come as the company faces an earnings shortfall, analyst price targets that exceed current trading levels, and an upcoming PDUFA date for deramiocel.
A director of RH sold 11,000 shares on March 31, 2026, generating roughly $1.5 million in proceeds across multiple trades. The director also exercised options to acquire 11,000 shares at $39.42. The moves come as RH stock has fallen sharply over the past year and several brokerages have trimmed price targets following disappointing quarterly result…
Capricor Therapeutics director Sabar Karimah Es sold a combined 115,000 shares of common stock in two trades totaling about $3.5 million, after exercising options to acquire the same number of shares at $4.86 each. The sales, executed under a 10b5-1 plan adopted in December 2025, took place March 31 and April 1, 2026. The company recently reported …
Universal Safety Products, Inc. (NASDAQ: UUU) disclosed that director Ault Milton C III purchased shares totaling $72,808 across transactions on March 30 and 31. The company also reported issuing 405,000 shares between January 26 and February 3 as part of a convertible note conversion totaling $1,503,424.80, executed under a Section 4(a)(2) exempti…
Steven S. Fendley, President of Kratos Defense & Security Solutions' U.S. division, sold 6,998 shares of the company's common stock on March 30, 2026, realizing about $487,119. The transactions occurred under a 10b5-1 trading plan adopted May 12, 2025. The move comes as Kratos shares have fallen 15% over the prior week but remain up 131% year-over-…
MediaAlpha director Steven Yi reported the sale of 12,000 shares of Class A common stock across three trades from March 30 to April 1, 2026, raising $111,907. The transactions, disclosed on a Form 4 filing, were executed under a Rule 10b5-1 trading plan to cover tax liabilities from vested restricted stock units. The company recently posted Q4 2025…
Caddis Holdings, LP, a roughly 10% shareholder in Fermi Inc. (FRMI), disposed of 11,000,000 shares of common stock in two transactions on March 30 and March 31, 2026, generating approximately $56,268,500. The sales occurred as Fermi's shares experienced pronounced volatility, falling 19% over the prior week and 83% over the trailing year. Following…
Realty Income Corp director Gregory McLaughlin sold 3,275 shares on April 1, 2026, for $61.87 apiece, totaling $202,624. The transaction leaves McLaughlin with 34,993 shares held by a family trust. The REIT, with a market value of $57.86 billion and a 5.25% dividend yield, is trading above its InvestingPro Fair Value. Separately, the company priced…
Cheniere Energy EVP and CFO Zach Davis sold 29,000 shares of common stock on March 30, 2026, for $300 per share, a transaction valued at $8.7 million. After the sale Davis holds 87,146 shares. Independent valuation commentary cites potential overvaluation versus Fair Value despite a P/E of 11.38. Separately, Cheniere reported strong fourth-quarter …
Tesla director Kathleen Wilson-Thompson sold 20,008 shares on March 30, 2026 for roughly $9.27 million and exercised options to acquire 40,000 additional shares at $14.99 each. The transactions leave her with 47,748 shares directly owned. The moves occur amid divergent analyst price targets and commentary on deliveries and regional demand.
Elena Ridloff, a director at Kymera Therapeutics, sold 12,000 shares of the company's common stock on March 31 and April 1, 2026, for just over $1 million. The transactions, reported on a Form 4 with the SEC, occurred at prices between $85.1946 and $86.05. On those same dates she exercised options to buy 12,000 shares at $14.18 per share. Separatel…
Kymera Therapeutics Chief Operating Officer Jeremy G. Chadwick sold 22,240 shares across March 31 and April 1, 2026, for about $1.9 million, executing trades under a pre-arranged Rule 10b5-1 plan. The transactions coincided with a year of strong stock performance and followed option exercises that acquired the same number of shares at a strike of $…
C3.ai Chief Executive Officer Stephen Bradley Ehikian sold 52,194 Class A shares on March 31 for roughly $429,092, trimming his direct stake to 721,485 shares. The transactions coincide with the stock trading close to its 52-week low and follow disappointing quarterly results and lowered guidance that prompted multiple analyst target cuts.
Velocity Financial, Inc. (NASDAQ: VEL) saw its chief financial officer, Mark R. Szczepaniak, sell 1,573 shares on April 1, 2026, for $18.13 apiece, generating $28,518 in proceeds. The move leaves him with 101,535 shares held directly and 71,546 held indirectly via a family trust. The transaction coincides with a company trading at a P/E of 6.56 and…
Saria Tseng, Executive Vice President and General Counsel of Monolithic Power Systems Inc. (MPWR), sold 25,094 shares on March 30, 2026, realizing approximately $25.9 million. The trades were conducted under a pre-established Rule 10b5-1 plan. The company recently reported stronger-than-expected fourth-quarter 2025 results and several firms raised …
Beam Therapeutics Inc. CEO John M. Evans disposed of 50,000 shares of common stock on March 30 and 31, 2026, generating about $1.1 million at weighted average prices between $22.3692 and $22.7634. On the same dates he purchased 50,000 shares at $0.67 for $33,500 and acquired a further 90,000 shares at no cost. After these transactions Evans holds 1…
Former Meridian Holdings director and CEO Anthony Brian Goodman and the institutional group Luxor Capital LLC reported direct sales totaling $50,536 across two trading days in late March 2026. The transactions came amid recent company moves including a material debt reduction, a reverse stock split and corporate name change, and routine executive a…
Jacob Zabkowicz, chief executive of Hudson Talent Solutions LLC - a Star Equity Holdings subsidiary - purchased 150 shares of Star Equity Holdings, Inc. (NASDAQ:STRR) on March 31, 2026, at $10.61 per share, a transaction valued at $1,591. The purchase raises his direct holdings to 180,863 shares, comprising 135,456 restricted stock units and 45,407…
Star Equity Holdings Chief Executive Officer Jeffrey Eberwein disposed of 7,722 shares of Series A Preferred Stock on March 30, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at $9.95 each for total proceeds of $76,833. After the sale Eberwein directly holds 764,217 shares of Star Equity Holding…
The Hershey Trust Co., acting as trustee for the Milton Hershey School, sold 29,000 shares of Hershey Co. (NASDAQ: HSY) common stock across March 30 to April 1, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The disposals generated $6.26 million in proceeds, at prices between $200.7672 and $215.0655. Following the s…
